The FDA has authorized urcosimod 0.05% for single-patient expanded access, or compassionate use, in a patient with neuropathic corneal pain, according to a press release from Okyo. WAIKOLOA, Hawaii — ...

Influence of Elephant-Driven Vegetation Structure and Altitudinal Gradient on the Occurrence of the Endemic Mount Cameroon Francolin ...

Holiday celebrations in Torrington maintain their small-town charm, with Christmas parades featuring local children and ...